Cancer

Breast cancer in India: 16% of women aged 55-64 face the silent threat

The rise in breast cancer cases has been linked to various factors, including late pregnancies, family history, hormonal changes, and lifestyle habits like smoking and high stress

ICMR predicts surge in cancer cases between 2022 and 2045 in BRICS nations

Cancer cases in India to surge in India, especially mouth cancer among men and breast cancer among women, reveals ICMR study on BRICS countries

Cancer-causing agents in cakes: Check out some healthier alternatives

Several carcinogenic substances were found in 12 cake samples collected from different Bengaluru bakeries. Here are some healthy alternatives to meet your craving

Ovarian cancer cure? Oxford's vaccine could stop it before it even starts

OvarianVax, a promising cancer vaccine, is in early development as researchers identify proteins on ovarian cancer cells that trigger immune responses

Zydus Lifesciences receives USFDA approval to produce prostrate cancer drug

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate cancer treatment drug. The company has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture Enzalutamide tablets (40 mg and 80 mg), the drug maker said in a regulatory filing. Enzalutamide tablets are androgen receptor inhibitors indicated for the treatment of patients with castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer. The product would be manufactured at the Group's manufacturing site at SEZ, Ahmedabad. As per IQVIA MAT July 2024 data, Enzalutamide tablets (40 mg and 80 mg) had annual sales of USD 1,417.2 million in the US. The Zydus group now has 400 approvals and has so far filed over 465 Abbreviated New Drug Application (ANDAs) since the commencement of the filing process in FY 2003-04, it said.

Sun Pharma signs licensing pact with Philogen for cancer medication

Sun Pharmaceutical Industries on Tuesday said it has inked a global licensing pact with Italian-Swiss firm Philogen for an anti-cancer drug. As per the agreement, Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun, a speciality product of Philogen. Fibromun, an innovative anti-cancer immunotherapy, is being investigated in registration trials by Philogen for the treatment of soft tissue sarcoma and glioblastoma. As per the pact, Philogen will complete the ongoing pivotal clinical trials for the product, pursue marketing authorisation with regulatory authorities, and manufacture commercial supplies, the Mumbai-based drug major said in a statement. Sun Pharma will be responsible for commercialisation activities, it added. The two partner companies will share post-commercialisation economics in about 45(Philogen):55(Sun Pharma) ratio, Sun Pharma said. The company did not disclose other financial terms. "Fibromun's progress through development has been qui

J&J raises baby powder settlement offer to more than $8.2 billion

J&J recently garnered support from more than 75 per cent of baby powder claimants for an out-of-court deal that includes claims that the talc-based version caused ovarian and other gynecological cance

J&J gets $260 million talc verdict overturned in Oregon, new trial ordered

J&J is facing claims by more than 62,000 plaintiffs that its baby powder and other talc products were contaminated with asbestos and caused cancer

Obesity-linked cancer rates surge in China; young adults most affected

From 2007 to 2021, obesity-related cancer rates in China rose by 3.6% annually, with a striking 15.3% increase for those aged 25 to 29, while rates for non-obesity-linked cancers stayed stable

Crucial to focus on cancers unique to low, middle-income nations: US expert

Low and middle-income countries are grappling with dual burden of non-communicable diseases and infection ailments, and it is crucial to "direct more attention" towards cancers prevalent or unique to such countries, a US-based cancer expert has said. Citing data, Dr Shobha Krishnan also said that as cancer cases in India are projected to rise by nearly 13 per cent by 2025 compared to 2020, the "urgency to exchange knowledge and best practices is critical". Krishnan, founder and president of US-based Global Initiative Against HPV and Cervical Cancer (GIAHC), was in India recently to take part in the first-ever US-India cancer dialogue held in Delhi earlier this month. In June 2023, President Joe Biden and Prime Minister Narendra Modi had reaffirmed the strong health partnership between the US and India by announcing new commitments to accelerate the fight against cancer, including convening a US-India cancer dialogue to advance the prevention, early detection, and treatment of ...

World Lung Cancer Day 2024: Know history, significance, theme and more

Lung cancer happens when the cancer cells start developing in the lungs. To spread awareness among people, World Lung Cancer Day is observed every year on August 1

Cancer cases rising, prices of essential drugs kept in check: Nadda

The government makes all efforts to ensure affordable and accessible treatment is available for cancer patients amid a rise in cases in India, Health Minister JP Nadda said on Friday. Replying to supplementary questions during Question Hour in the Lok Sabha, Nadda said the government made all efforts to ensure that affordable and accessible treatment was available to the patients. "The number of cancer cases is going up, it is increasing by almost 2.5 per cent every year," Nadda said. In men, cases of oral and lung cancer are on the up while more women are getting breast cancer, he added. More than 15.5 lakh cancer cases are being registered every year, Nadda said. "There is a list of 131 essential cancer medicines, which are in Schedule 1, (that) are monitored and (their) pricing is decided by the government. These are the commonly used medicines," Nadda said. He said patients cumulatively saved around Rs 294 crore due to this price control. "There are 28 combinations, which ar

King Charles III to visit Australia, Samoa as he recovers from cancer

King Charles III is preparing to visit Australia and Samoa in October, an itinerary that will span 12 time zones and test the monarch's stamina as he recovers from cancer treatment. The trip, announced on Sunday by Buckingham Palace, marks a watershed moment for the 75-year-old king, who has been slowly returning to public duties after taking a break following his cancer diagnosis in early February. The decision to undertake such a long journey will be seen as a sign of Charles' recovery, even though the program in Australia will be limited. The visit to Australia will be a critical moment for the king as he tries to shore up support for the monarchy at home and abroad. The trip will mark the first time since he ascended the throne that Charles will visit one of the 14 countries outside the United Kingdom where the British monarch remains head of state, a link that is a source of pride for some but an unwelcome reminder of Britain's colonial dominance for others. While he will ...

Most lung cancer patients in India are non-smokers, study reveals

A recent study highlights the role of poor air quantity in India and genetic diversity in rapidly increasing cases of lung cancer

Rising cases of Breast cancer: Everything you need to know so far

Actor Hina Khan's recent stage 3 diagnosis underscores a concerning trend of breast cancer amongst younger women. So here's all about the breast cancer impacting overall survival and future recurrence

HealthCare Global Enterprises acquires Andhra-based MGCHRI for Rs 414 cr

This move positions HCG as a leader in a highly attractive micro-market, benefiting from a high-quality primary catchment area and substantial secondary catchment from neighboring states

J&J talc users want cancer checks for women even if it cost billions

The suit is the latest salvo in the ongoing legal battle between J&J and former talc users, who allege the world's largest maker of health-care products hid the cancer risks of its iconic baby powder

Kate Middleton makes first public appearance since cancer diagnosis

Britain put on a display of birthday pageantry Saturday for King Charles III, a military parade that marked the Princess of Wales' first public appearance since her cancer diagnosis early this year. The annual event was also a show of stability by the monarchy after months in which both the king and Kate, wife of heir to the throne Prince William, have been sidelined by cancer treatment. Kate joined other members of the royal family on a Buckingham Palace balcony at the end of the King's Birthday Parade. The family and crowds outside the palace watched a flyby of military aircraft to cap ceremonies marking the monarch's official birthday Kate announced Friday that she would attend the royal birthday celebrations after making progress in her treatment. She disclosed in March that she was undergoing chemotherapy for an unspecified form of cancer. It was her first public appearance since December. I am making good progress, but as anyone going through chemotherapy will know, there are

GSK faces lawsuit from lab that found probable carcinogen in Zantac

Big drugmakers already face some 80,000 state suits from users of the drug who say their cancers were caused by Zantac contaminated with NDMA, the dangerous chemical Valisure discovered

Jet Airways founder Naresh Goyal's wife Anita dies after battling cancer

Naresh Goyal was granted interim bail earlier this month to be with his wife; he is under arrest in a money laundering case